Jean-Charles Soria: Biological approaches have led to numerous advances in cancer

Jean-Charles Soria shared a post on LinkedIn:

“Biological approaches have led to numerous advances in cancer but integrating fields across engineering and the physical sciences may accelerate cancer discovery and therapy.”

Read further.
Source: Jean-Charles Soria/LinkedIn

Jean-Charles Soria serves as Amgen’s senior vice president of Oncology within Global Development. He is a medical oncologist and a professor of medicine at Paris-Saclay University. From 2017 to 2019, he was the senior vice president of Research and Development in Oncology at AstraZeneca. Additionally, Soria has authored or co-authored over 670 articles in leading international journals and has been recognized as one of the world’s most influential research scientists.